Greenwich LifeSciences Inc.
Organization details
- Legal name
- Greenwich LifeSciences Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Stafford
- Headquarters state / province
- Texas
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- GLSI
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001799788
- EIN
- 20-5473709
Board of directors
-
David McWilliams · DirectorSince 2024
-
Eric Rothe · DirectorSince 2024
-
Frank Joseph Daugherty · Director · Chief Medical OfficerSince 2024
-
Kenneth Hallock · DirectorSince 2024
-
Snehal Patel · Director · CEO and CFOSince 2023
Chief executives
Director election results
Annual meeting of December 18, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
100.0%
-
100.0%
-
100.0%
-
100.0%
-
100.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $475,672
- 11 purchases by 1 insider
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 29, 2026 | Snehal Patel Director, Officer (CEO and CFO), 10% owner | Open-market purchase | +700 | $13.10 | $9,170 |
| Jul 28, 2026 | Snehal Patel Director, Officer (CEO and CFO), 10% owner | Open-market purchase | +1,500 | $13.59 | $20,385 |
| Jul 27, 2026 | Snehal Patel Director, Officer (CEO and CFO), 10% owner | Open-market purchase | +1,500 | $13.62 | $20,430 |
| Jul 24, 2026 | Snehal Patel Director, Officer (CEO and CFO), 10% owner | Open-market purchase | +1,100 | $12.88 | $14,168 |
| Jul 23, 2026 | Snehal Patel Director, Officer (CEO and CFO), 10% owner | Open-market purchase | +2,500 | $13.14 | $32,850 |
| Jan 13, 2026 | Snehal Patel Director, Officer (CEO and CFO), 10% owner | Open-market purchase | +1,800 | $29.83 | $53,694 |
| Jan 12, 2026 | Snehal Patel Director, Officer (CEO and CFO), 10% owner | Open-market purchase | +2,900 | $27.54 | $79,866 |
| Dec 31, 2025 | Snehal Patel Director, Officer (CEO and CFO), 10% owner | Open-market purchase | +4,300 | $21.36 | $91,848 |
| Dec 30, 2025 | Snehal Patel Director, Officer (CEO and CFO), 10% owner | Open-market purchase | +2,900 | $21.73 | $63,017 |
| Dec 18, 2025 | Snehal Patel Director, Officer (CEO and CFO), 10% owner | Open-market purchase | +4,100 | $12.62 | $51,742 |
| Nov 25, 2025 | Snehal Patel Director, Officer (CEO and CFO), 10% owner | Open-market purchase | +4,600 | $8.37 | $38,502 |
| Nov 7, 2025 | Snehal Patel Director, Officer (CEO and CFO), 10% owner | Open-market purchase | +10,600 | $8.43 | $89,358 |
| Oct 31, 2025 | Snehal Patel Director, Officer (CEO and CFO), 10% owner | Open-market purchase | +2,300 | $9.26 | $21,298 |
| Apr 25, 2025 | Snehal Patel Director, Officer (CEO and CFO), 10% owner | Open-market purchase | +3,600 | $9.88 | $35,568 |
| Apr 17, 2025 | Snehal Patel Director, Officer (CEO and CFO), 10% owner | Open-market purchase | +5,400 | $8.98 | $48,492 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Greenwich LifeSciences Inc.
Who is the CEO of Greenwich LifeSciences Inc.?
Snehal Patel is Greenwich LifeSciences Inc.'s CEO and CFO.
How many directors are on Greenwich LifeSciences Inc.'s board?
Greenwich LifeSciences Inc.'s board has 5 directors: David McWilliams, Eric Rothe, Frank Joseph Daugherty, Kenneth Hallock and Snehal Patel.
Are Greenwich LifeSciences Inc. insiders buying or selling shares?
Over the last 12 months, Greenwich LifeSciences Inc. insiders bought $475,672 of shares in 11 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="greenwich-lifesciences-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.